Agilent Presents Thought Leader Award to Professor Antoni Ribas
April 12 2019 - 11:00AM
Business Wire
Renowned melanoma physician-researcher recognized for his
research in cancer genomics and immunotherapy
Agilent Technologies Inc. (NYSE: A) today announced that
Professor Antoni Ribas has received an Agilent Thought Leader Award
in support of his genomics and immunotherapy research. A renowned
oncologist, Dr. Ribas is implementing next-generation genomics
solutions to identify mechanisms and biomarkers associated with
resistance and response to immunotherapy in patients with
melanoma.
Dr. Ribas is a professor of medicine and surgery as well as
molecular and medical pharmacology at the University of California
at Los Angeles (UCLA). He also directs the Tumor Immunology Program
at UCLA’s Jonsson Comprehensive Cancer Center and the Parker
Institute for Cancer Immunotherapy (PICI) Center at UCLA.
“I’m very honored to receive this award and be given the
opportunity to further my research on the deadliest form of skin
cancer,” said Dr. Ribas. “By partnering with Agilent, my laboratory
will be able to intensify our research efforts in developing new
treatment strategies for the many patients who still do not respond
to current therapies.”
“Agilent is pleased to partner with leading researchers such as
Dr. Ribas to help advance our understanding of patient response to
immunotherapies,” said Kamni Vijay, Agilent vice president, and
general manager of the company’s Genomics Division. “Within the
growing immuno-oncology field, we hope that the discovery of new
resistance and response mechanisms will lead to additional
biomarker discovery and ultimately to better treatment options for
patients.”
Vijay noted that such biomarkers can further impact the process
of patient selection for immunotherapeutic treatment and could help
scientists identify new alternative drugs targets.
The Agilent Thought Leader Program promotes fundamental
scientific advances by contributing financial support, products,
and expertise to the research of influential thought leaders in the
life sciences, diagnostics, and chemical analysis space. Further
information is available on Agilent's Thought Leader Program
web page.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life
sciences, diagnostics and applied chemical markets. With more than
50 years of insight and innovation, Agilent instruments, software,
services, solutions, and people provide trusted answers to
customers' most challenging questions. The company generated
revenues of $4.91 billion in fiscal 2018 and employs 15,300 people
worldwide. Information about Agilent is available at
www.agilent.com. To receive the latest Agilent news, subscribe to
our Newsroom. Follow Agilent on LinkedIn, Twitter, and
Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190412005235/en/
Naomi GoumilloutAgilent
Technologies+1.781.266.2819naomi.goumillout@agilent.com
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Aug 2024 to Sep 2024
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Sep 2023 to Sep 2024